Biotech Values

[Titan V]

Any thoughts on CATB in general Dew? They had decent p2 data and their DMD drug is said to be able to target 86% of DMD mutations vs much lower % for SRPT. They also have a collaboration with SRPT. Wondering if they are trimming staff for a sale. They are low on cash but haven’t raised for some time.